Atlas Trials

5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females

Clinical trial NCT02356107 · COMPLETED

Trial details

NCT number
NCT02356107
Sponsor
Perry Renshaw
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2015-04-01
Primary completion
2016-08-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.